AlphaYouRDHL: Raday Gilead discloses securities transactions
By AlphaYouPublished Form 4
Raday Gilead
Reporting filer
Raday Gilead reported Sale in RedHill Biopharma Ltd.: 14310000 units of Ordinary Shares, dated 2026-10-01. The full Form 4 contains 2 transaction entries.
- Disclosed
- Oct 6, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Raday Gilead | 2026-10-01 | S | Sale | 14310000 | 0.0001 | 176,910,000 | 5 days | Filed terms
|
| American Depository Shares (derivative) | Raday Gilead | 2026-10-01 | M | Exercise or conversion | 27560000 | 0 | 131,690,000 | 5 days | Filed terms
|
Ordinary Shares
- Owner
- Raday Gilead
- Date
- 2026-10-01
- Code
- S
- Action
- Sale
- Quantity
- 14310000
- Price
- 0.0001
- Following holdings
- 176,910,000
- Reporting delay
- 5 days
- Filed terms and references
Filed terms
- security Title: Ordinary Shares
- transaction Date: 2026-10-01
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Timeliness:
- transaction Shares: 14310000
- id: F1
- transaction Price Per Share: 0.0001
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 176910000
- direct Or Indirect Ownership: D
American Depository Shares (derivative)
- Owner
- Raday Gilead
- Date
- 2026-10-01
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 27560000
- Price
- 0
- Following holdings
- 131,690,000
- Reporting delay
- 5 days
- Filed terms and references
Filed terms
- security Title: American Depository Shares
- id: F3
- transaction Date: 2026-10-01
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 27560000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F3
- id: F3
- underlying Security Title: Ordinary Shares
- underlying Security Shares: 27560000
- shares Owned Following Transaction: 131690000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Raday Gilead: Chief Operating Officer.
- F1: The reporting person sold 1,431 American Depository Shares ("ADS"), of RedHill Biopharma Ltd. (the "Issuer"), each ADS represents 10,000 ordinary shares, which have no par value effective August 7, 2026, solely to satisfy tax withholding obligations incurred upon the vesting of an aggregate of 4,187 Restricted Share Units ("RSU") granted to him on March 26, 2025, and January 23, 2026. Such transaction was effected by the trustee appointed in accordance with the regulations set by the Israeli Tax Authority pursuant to a sell to cover policy and does not represent a discretionary trade by the reporting person.
- F2: The price reported in Table 1 Column 4 is $0.465 per ADS, which would be equivalent to $0.0000465 per ordinary share.
- F3: Each ADS is convertible at any time, at the holder's election, for no consideration and has no expiration date.
Original sources
Prepared automatically from public filing data. Report a correction.